On November 4, 2026, NASDAQ approved the listing of Canary Capital on Staked INJ ETF, which has paved the way for Injective's INJ tokens to enter the regulated U.S. securities market and may bring along collateral yields. The approval of this ETF for Injective is seen as a milestone for institutionalization, but it does not mean that trading has already begun. On the other hand, the price of INJ has rebounded to around $7.64, reaching a closely watched breakout level.
Abstract
- The Staked INJ ETF of Canary Capital has received approval for listing on NASDAQ.
- The fund combines the INJ exposure with potential pledge earnings.
- INJ rose by about 9% within 24 hours to around $7.64.
- Listing approval and the official launch of trading for ETF are two different steps.
The INJ ETF of Injective has been approved, paving the way for regulated investments.
Through the Staked INJ ETF of Canary Capital, INJ now has its first regulated exchange-traded product that can be traded in the United States. This product combines traditional investment channels with crypto collateral exposures, providing investors with an option different from directly holding tokens.
The fund is designed to enable investors to obtain a INJ exposure as well as potential pledge earnings, without the need to manage tokens or set up pledge infrastructure themselves. The exchange-traded format also makes it easier for investors who prefer traditional brokerage accounts to access this asset.
According to Eagle.inj, this approval reflects years of development, innovation, and ecosystem growth. For Injective, this milestone opens up a channel to meet institutional demand through regulated securities market products.
However, market approval does not equate to the immediate commencement of trading. The launch of the fund and the participation of subsequent investors are still independent developments; the approval alone does not indicate the level of demand.
INJ broke through $7.30, but technical signals remain divided
It is reported that INJ has risen to around $7.64, surpassing the $7.30 breakthrough level pointed out by crypto analyst Trader Symba. Market data shows that its increase over the past 24 hours was approximately 9%.
Trader Symba indicates that INJ has broken through the wedge pattern and successfully backtested the breakout area. The analyst considers $7.30 to be a resistance level that has been overcome by the buyers, with a preliminary target of $7.55, and higher extension targets ranging between $8.00 and $8.20.
The price of $7.64 mentioned in the report has already exceeded this first target. A higher range is still a conditional prediction, depending on whether the buying pressure can continue and whether the breakout structure can be maintained.
The signals given by the moving averages are not so clear. The price is above the 7-day moving average, but still below the 20-day moving average, which is close to $7.92. Its Relative Strength Index (RSI) is around 50, indicating relatively neutral momentum, rather than a clear confirmation of a stronger upward trend.
ETF Starting with $7.92 will be the next step in testing.
Staked INJ ETF The final initiation of trading and the initial inflow of funds will more clearly reflect the needs of institutions. In terms of the price chart, if it can remain above $7.92, it will help to strengthen this rebound and bring the higher target range for Trader Symba into sight.
The approval of Injective INJ ETF and the breakthrough in token prices represent two different developments: the former establishes a listing channel on exchanges, while the latter reflects a price recovery as reported in the media. The actual participation of funds will provide evidence of investors' interest that goes beyond merely the approval itself.
In terms of technical patterns, sustained buying pressure is still a prerequisite for achieving higher price targets. After a breakout, $7.30 can serve as a support level, while the 20-day moving average is around $7.92.
This article was generated with the assistance of artificial intelligence and has been reviewed by an editorial team.
Amelia Tomasicchio
As a digital marketing expert, Amelia entered the fintech industry in 2014 after writing a paper on Bitcoin technology. She had previously contributed to several international cryptocurrency magazines and served as the Chief Marketing Officer for Eidoo. She is currently a co-founder of The Cryptonomist and also a marketing instructor at Digital Coach in Milan. She has also written a book about NFT for Mondadori publishing house and has helped artists and companies enter this field. As a consultant, Amelia has also participated in metaverse-related projects such as The Nemesis and OVER.
